MedMira Inc., a global market leader in premium rapid diagnostic solutions, announced today that it will host a conference call with analysts to discuss the company's second quarter financial results and provide a corporate update beginning at 9:00 am EST (10:00 am AST) on Wednesday, March 7, 2007. MedMira's second quarter financial results were released on March 1, 2007 and are available on the MedMira website at www.medmira.com.
In order to listen to the conference call, please dial 1-800-589-8577 toll-free anywhere in Canada or the USA, or 1-416-644-3425 in the Toronto area.
A replay of the call will be available until 23:59 pm EST, Wednesday, March 14, 2007 and may be accessed by dialing 1-800-289-8525 toll-free anywhere in Canada or the USA, or 1-416-640-1917 in the Toronto area, and entering the pass code 21222235# anytime after the call has ended.
About MedMira
MedMira is a leading developer and manufacturer of flow-through rapid diagnostics. The company's tests provide hospitals, labs, clinics and individuals around the world with reliable, rapid diagnosis for diseases such as HIV and hepatitis C in just three minutes. The company's tests are sold under the Reveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global markets. MedMira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the
European Union.
The company's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada with a representative office in China. For more information visit MedMira's website at www.medmira.com. -- www.cnxmarketlink.com
Stay in touch with HULIQ NEWS on Twitter @HULIQ
Comments
Post new comment